Malignant Tumor Of Thyroid Gland — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for malignant tumor of thyroid gland. 116 active patents protecting 1 drugs from 1+ originators. First major cliff: 2031. Daily refresh.

1
Approved drugs
116
Active US patents
51/100
Avg vulnerability
—
Annual revenue covered

Originators in Malignant Tumor Of Thyroid Gland

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Fresenius Kabi 116 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating malignant tumor of thyroid gland. Each bar = one year. Y-axis scaled to peak year (30 patents).

1
31
9
32
1
35
10
36
30
37
20
38
15
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Unithroid
LEVOTHYROXINE SODIUM
 Fresenius Kabi 116 51 — 2031-08-06

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11241382 Unithroid method of use 70 2039-09-17
11241382 Unithroid method of use 70 2039-09-17
11241382 Unithroid method of use 70 2039-09-17
11241382 Unithroid method of use 70 2039-09-17
11241382 Unithroid method of use 70 2039-09-17
11241382 Unithroid method of use 70 2039-09-17
11241382 Unithroid method of use 70 2039-09-17
11241382 Unithroid method of use 70 2039-09-17
11241382 Unithroid method of use 70 2039-09-17
11241382 Unithroid method of use 70 2039-09-17

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11096913 Unithroid formulation 42 2037-02-28
11096913 Unithroid formulation 42 2037-02-28
10537538 Unithroid formulation 42 2037-02-28
10537538 Unithroid formulation 42 2037-02-28
11096913 Unithroid formulation 42 2037-02-28
11096913 Unithroid formulation 42 2037-02-28
11096913 Unithroid formulation 42 2037-02-28
10537538 Unithroid formulation 42 2037-02-28
10537538 Unithroid formulation 42 2037-02-28
11096913 Unithroid formulation 42 2037-02-28

Related